US Stock MarketDetailed Quotes

Arbutus Biopharma (ABUS)

Watchlist
  • 4.350
  • -0.020-0.46%
Close Apr 14 16:00 ET
  • 4.300
  • -0.050-1.15%
Post 20:01 ET
850.33MMarket Cap-25.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma (ABUS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.88%-39.64M
54.63%-4.68M
71.95%-5.82M
-8.58%-15.75M
30.60%-13.39M
24.54%-64.85M
40.35%-10.32M
4.81%-20.74M
25.84%-14.5M
29.32%-19.3M
Net income from continuing operations
52.09%-33.5M
70.03%-3.76M
60.73%-7.74M
112.74%2.52M
-37.21%-24.53M
4.02%-69.92M
35.11%-12.53M
1.92%-19.72M
-15.81%-19.8M
-9.40%-17.88M
Operating gains losses
---674K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-73.70%363K
-96.70%11K
-96.73%11K
-96.91%11K
-7.04%330K
-1.71%1.38M
-7.24%333K
-8.94%336K
4.09%356K
6.29%355K
Other non cash items
-742.12%-3.22M
-306.48%-2.9M
121.00%42K
26.69%-239K
67.90%-121K
114.99%501K
250.97%1.4M
57.63%-200K
73.56%-326K
46.75%-377K
Change In working capital
-254.29%-10.02M
885.15%1.8M
146.02%1.15M
-761.35%-18.24M
284.30%5.27M
84.48%-2.83M
-115.40%-229K
26.11%-2.5M
168.88%2.76M
76.82%-2.86M
-Change in receivables
317.22%1.38M
83.90%-129K
-24.53%120K
-57.80%157K
438.02%1.23M
-49.29%-633K
-302.78%-801K
-64.11%159K
644.00%372K
72.33%-363K
-Change in prepaid assets
-26.11%1.7M
12.58%1.3M
-12.24%1.04M
-1,007.76%-1.05M
364.74%413K
343.69%2.3M
5.10%1.15M
181.00%1.19M
206.42%116K
66.67%-156K
-Change in payables and accrued expense
22.24%-2.11M
3,930.00%806K
104.07%145K
-365.68%-7.6M
324.56%4.55M
52.99%-2.71M
-95.70%20K
-456.04%-3.56M
437.38%2.86M
68.26%-2.02M
-Change in other current liabilities
-29.53%-557K
-42.74%-177K
0.64%-155K
-55.13%-121K
-44.44%-104K
3.15%-430K
20.00%-124K
-9.86%-156K
-6.85%-78K
2.70%-72K
-Change in other working capital
-668.90%-10.43M
--0
--0
-1,775.63%-9.62M
-232.79%-812K
87.27%-1.36M
-51.43%-477K
96.18%-123K
83.04%-513K
94.05%-244K
Cash from discontinued investing activities
Operating cash flow
38.88%-39.64M
54.63%-4.68M
71.95%-5.82M
-8.58%-15.75M
30.60%-13.39M
24.54%-64.85M
40.35%-10.32M
4.81%-20.74M
25.84%-14.5M
29.32%-19.3M
Investing cash flow
Cash flow from continuing investing activities
-32.11%15.58M
-110.15%-1.36M
16.41%-10.02M
58.83%15.61M
-2.95%11.35M
-54.80%22.95M
-39.66%13.41M
-214.93%-11.99M
582.10%9.83M
-29.88%11.69M
Net PPE purchase and sale
300.00%364K
512.79%355K
--0
1,000.00%9K
--0
81.58%-182K
---86K
--0
99.88%-1K
18.80%-95K
Net business purchase and sale
----
----
----
----
----
----
----
----
----
0.50%37.19M
Net investment purchase and sale
-34.22%15.22M
-112.71%-1.72M
16.41%-10.02M
58.72%15.6M
-3.73%11.35M
-55.31%23.13M
-39.27%13.5M
-214.80%-11.99M
-74.99%9.83M
158.35%11.79M
Cash from discontinued investing activities
Investing cash flow
-32.11%15.58M
-110.15%-1.36M
16.41%-10.02M
58.83%15.61M
-2.95%11.35M
-54.80%22.95M
-39.66%13.41M
-214.93%-11.99M
582.10%9.83M
-29.88%11.69M
Financing cash flow
Cash flow from continuing financing activities
-89.00%5.72M
15.41%1.64M
-52.45%844K
-98.14%453K
-88.60%2.78M
69.66%52M
-62.67%1.42M
5.59%1.78M
413.92%24.37M
19.66%24.43M
Net common stock issuance
--0
--0
--0
--0
--0
47.81%44.12M
-100.03%-1K
--0
371.51%22.36M
9.58%21.77M
Proceeds from stock option exercised by employees
-27.33%5.72M
15.33%1.64M
-52.45%844K
-77.47%453K
4.47%2.78M
890.31%7.87M
3,260.00%1.42M
522.81%1.78M
--2.01M
380.18%2.67M
Cash from discontinued financing activities
Financing cash flow
-89.00%5.72M
15.41%1.64M
-52.45%844K
-98.14%453K
-88.60%2.78M
69.66%52M
-62.67%1.42M
5.59%1.78M
413.92%24.37M
19.66%24.43M
Net cash flow
Beginning cash position
38.22%36.33M
-29.64%22.41M
-40.42%37.41M
-13.98%37.08M
38.22%36.33M
-14.59%26.29M
81.66%31.85M
130.86%62.79M
6.23%43.1M
-14.59%26.29M
Current changes in cash
-281.65%-18.34M
-197.43%-4.4M
51.56%-14.99M
-98.40%315K
-95.59%742K
323.52%10.09M
-48.32%4.52M
-219.90%-30.95M
247.24%19.7M
71.83%16.83M
Effect of exchange rate changes
128.57%14K
103.03%1K
-340.00%-12K
362.50%21K
130.77%4K
-296.00%-49K
-335.71%-33K
-37.50%5K
-700.00%-8K
-425.00%-13K
End cash Position
-50.43%18.01M
-50.43%18.01M
-29.64%22.41M
-40.42%37.41M
-13.98%37.08M
38.22%36.33M
38.22%36.33M
81.66%31.85M
130.86%62.79M
6.23%43.1M
Free cash flow
39.05%-39.64M
55.00%-4.68M
71.95%-5.82M
-8.58%-15.75M
30.94%-13.39M
25.20%-65.03M
39.85%-10.4M
4.95%-20.74M
28.96%-14.51M
29.28%-19.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.88%-39.64M54.63%-4.68M71.95%-5.82M-8.58%-15.75M30.60%-13.39M24.54%-64.85M40.35%-10.32M4.81%-20.74M25.84%-14.5M29.32%-19.3M
Net income from continuing operations 52.09%-33.5M70.03%-3.76M60.73%-7.74M112.74%2.52M-37.21%-24.53M4.02%-69.92M35.11%-12.53M1.92%-19.72M-15.81%-19.8M-9.40%-17.88M
Operating gains losses ---674K------------------------------------
Depreciation and amortization -73.70%363K-96.70%11K-96.73%11K-96.91%11K-7.04%330K-1.71%1.38M-7.24%333K-8.94%336K4.09%356K6.29%355K
Other non cash items -742.12%-3.22M-306.48%-2.9M121.00%42K26.69%-239K67.90%-121K114.99%501K250.97%1.4M57.63%-200K73.56%-326K46.75%-377K
Change In working capital -254.29%-10.02M885.15%1.8M146.02%1.15M-761.35%-18.24M284.30%5.27M84.48%-2.83M-115.40%-229K26.11%-2.5M168.88%2.76M76.82%-2.86M
-Change in receivables 317.22%1.38M83.90%-129K-24.53%120K-57.80%157K438.02%1.23M-49.29%-633K-302.78%-801K-64.11%159K644.00%372K72.33%-363K
-Change in prepaid assets -26.11%1.7M12.58%1.3M-12.24%1.04M-1,007.76%-1.05M364.74%413K343.69%2.3M5.10%1.15M181.00%1.19M206.42%116K66.67%-156K
-Change in payables and accrued expense 22.24%-2.11M3,930.00%806K104.07%145K-365.68%-7.6M324.56%4.55M52.99%-2.71M-95.70%20K-456.04%-3.56M437.38%2.86M68.26%-2.02M
-Change in other current liabilities -29.53%-557K-42.74%-177K0.64%-155K-55.13%-121K-44.44%-104K3.15%-430K20.00%-124K-9.86%-156K-6.85%-78K2.70%-72K
-Change in other working capital -668.90%-10.43M--0--0-1,775.63%-9.62M-232.79%-812K87.27%-1.36M-51.43%-477K96.18%-123K83.04%-513K94.05%-244K
Cash from discontinued investing activities
Operating cash flow 38.88%-39.64M54.63%-4.68M71.95%-5.82M-8.58%-15.75M30.60%-13.39M24.54%-64.85M40.35%-10.32M4.81%-20.74M25.84%-14.5M29.32%-19.3M
Investing cash flow
Cash flow from continuing investing activities -32.11%15.58M-110.15%-1.36M16.41%-10.02M58.83%15.61M-2.95%11.35M-54.80%22.95M-39.66%13.41M-214.93%-11.99M582.10%9.83M-29.88%11.69M
Net PPE purchase and sale 300.00%364K512.79%355K--01,000.00%9K--081.58%-182K---86K--099.88%-1K18.80%-95K
Net business purchase and sale ------------------------------------0.50%37.19M
Net investment purchase and sale -34.22%15.22M-112.71%-1.72M16.41%-10.02M58.72%15.6M-3.73%11.35M-55.31%23.13M-39.27%13.5M-214.80%-11.99M-74.99%9.83M158.35%11.79M
Cash from discontinued investing activities
Investing cash flow -32.11%15.58M-110.15%-1.36M16.41%-10.02M58.83%15.61M-2.95%11.35M-54.80%22.95M-39.66%13.41M-214.93%-11.99M582.10%9.83M-29.88%11.69M
Financing cash flow
Cash flow from continuing financing activities -89.00%5.72M15.41%1.64M-52.45%844K-98.14%453K-88.60%2.78M69.66%52M-62.67%1.42M5.59%1.78M413.92%24.37M19.66%24.43M
Net common stock issuance --0--0--0--0--047.81%44.12M-100.03%-1K--0371.51%22.36M9.58%21.77M
Proceeds from stock option exercised by employees -27.33%5.72M15.33%1.64M-52.45%844K-77.47%453K4.47%2.78M890.31%7.87M3,260.00%1.42M522.81%1.78M--2.01M380.18%2.67M
Cash from discontinued financing activities
Financing cash flow -89.00%5.72M15.41%1.64M-52.45%844K-98.14%453K-88.60%2.78M69.66%52M-62.67%1.42M5.59%1.78M413.92%24.37M19.66%24.43M
Net cash flow
Beginning cash position 38.22%36.33M-29.64%22.41M-40.42%37.41M-13.98%37.08M38.22%36.33M-14.59%26.29M81.66%31.85M130.86%62.79M6.23%43.1M-14.59%26.29M
Current changes in cash -281.65%-18.34M-197.43%-4.4M51.56%-14.99M-98.40%315K-95.59%742K323.52%10.09M-48.32%4.52M-219.90%-30.95M247.24%19.7M71.83%16.83M
Effect of exchange rate changes 128.57%14K103.03%1K-340.00%-12K362.50%21K130.77%4K-296.00%-49K-335.71%-33K-37.50%5K-700.00%-8K-425.00%-13K
End cash Position -50.43%18.01M-50.43%18.01M-29.64%22.41M-40.42%37.41M-13.98%37.08M38.22%36.33M38.22%36.33M81.66%31.85M130.86%62.79M6.23%43.1M
Free cash flow 39.05%-39.64M55.00%-4.68M71.95%-5.82M-8.58%-15.75M30.94%-13.39M25.20%-65.03M39.85%-10.4M4.95%-20.74M28.96%-14.51M29.28%-19.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -